{
    "clinical_study": {
        "@rank": "82252", 
        "arm_group": [
            {
                "arm_group_label": "sepsis", 
                "description": "Patients with sepsis but not severe sepsis"
            }, 
            {
                "arm_group_label": "Severe sepsis", 
                "description": "Patients with severe sepsis"
            }, 
            {
                "arm_group_label": "SIRS", 
                "description": "Patients with SIRS after major orthopedics surgery"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Healthy volunteers"
            }
        ], 
        "biospec_descr": {
            "textblock": "Plasma"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "-  Molecules indicating endothelial injury may serve as biomarkers for severe sepsis\n           because of the critical role of endothelial injury in organ dysfunction during severe\n           sepsis.\n\n        -  HSPA12B is primarily located in endothelial cells and detectable during sepsis.\n\n        -  The investigators speculated that HSPA12B from endothelial cells might be correlated\n           with severe sepsis."
        }, 
        "brief_title": "HSPA12B as a Potential Biomarker for Sepsis and Severe Sepsis", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Sepsis", 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients\n\n          -  Patients meet the diagnostic criteria according to the grouping\n\n        Exclusion Criteria:\n\n          -  patients without informed consent\n\n          -  patients who were undergoing continuous renal replacement therapy before sampling\n\n          -  patients with special infection induced by virus, tubercle bacillus, mycoplasma,\n             Chlamydia, and so on"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Continuous patients with sepsis, severe sepsis, SIRS after major orthopedics surgery and\n        healthy volunteers"
            }
        }, 
        "enrollment": {
            "#text": "118", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847248", 
            "org_study_id": "HSPA12B-sepsis-biomarker"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sepsis", 
            "biomarker", 
            "HSPA12B"
        ], 
        "lastchanged_date": "November 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "zip": "200433"
                }, 
                "name": "Department of Anesthesiology and Intensive Care Medicine, Changhai Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "4", 
        "overall_official": {
            "affiliation": "Department of Anesthesiology and Intensive Care Medicine, Changhai Hospital", 
            "last_name": "Ke-ming Zhu, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: National Natural Science Foundation", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "mortality within 28 days after recruitment.", 
            "measure": "28-day mortality", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847248"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Changhai Hospital", 
            "investigator_full_name": "Jia-feng Wang", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Changhai Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Changhai Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}